AIDS activists have been vocal in urging the Food and Drug Administration to relax its standards and authorize for general use several experimental drugs that appear to help fight the disease. Even though many medical experts worry about the dangers of releasing relatively untested drugs to a broader population, the FDA made a controversial decision last year to allow wide distribution of certain drugs that are still in the testing phase. Among the first was DDI, or dideoxyinosine, an unproven medicine dubbed by its enthusiasts "AZT without tears." The reference is to the most commonly used anti-AIDS drug, which can produce...
To continue reading:
or
Log-In
